Annual report
4937.TEDINET S100XCAJ
Period2024-10-01 → 2025-09-30
Filed2025-12-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 132
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥1.9bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30v | Cons. | Net sales (5-year summary) |
| Operating income | ¥151m | 2024-10-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥56m | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥57m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥288m | 2022-10-01 → 2023-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥22m | 2021-10-01 → 2022-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥57m | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥28m | 2022-10-01 → 2023-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥57m | 2021-10-01 → 2022-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥17m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2023-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2022-09-30v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥993m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥773m | at 2023-09-30v | Cons. | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-09-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥906m | at 2022-09-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥136m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥49m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥456m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥169m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥189m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥49m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥112m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥129m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥12.32 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.03 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.43 | 2022-10-01 → 2023-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.04 | 2021-10-01 → 2022-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥12.24 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥9.32 | 2022-10-01 → 2023-09-30v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥591.15 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥590.33 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥256.73 | at 2023-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥246.98 | at 2022-09-30v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 65.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.9% | at 2023-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 2.1% | 2024-10-01 → 2025-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2022-10-01 → 2023-09-30v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 93 | at 2025-09-30 | Cons. | Number of employees |
| Employees | 86 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 50 | at 2023-09-30v | Cons. | Number of employees |
| Employees | 44 | at 2022-09-30v | Cons. | Number of employees |
| Revenue | ¥1.3bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥76m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥54m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥43m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥28m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥275m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥21m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥141m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥43m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥28m | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥45m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥30m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥32m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | −¥57m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥116m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.7bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥1.6bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥711m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥810m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥777m | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥801m | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥976m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2024-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2021-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥128m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥6m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥703m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-12.56 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.77 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.57 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.95 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.61 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥10.44 | 2022-10-01 → 2023-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥40.9 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥563.24 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥587.77 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥257.96 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥247.07 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥266.72 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 73.4% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.2% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.1% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,622,668 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,618,928 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,010,278 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,006,178 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,001,178 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 61 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 60 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 50 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 44 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 72 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥682,000 |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-09-30 | ¥9m |
| Reconciling Itemsreconciling | revenue external | 2024-10-01 → 2025-09-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥28m |
| Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥953m |
| Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥953m |
| Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥295m |
| Medical Supportreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥1.0bn |
| Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥999m |
| Medical Supportreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥1m |
| Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥216m |
| —segment total | capex | 2024-10-01 → 2025-09-30 | ¥262m |
| —segment total | depreciation | 2024-10-01 → 2025-09-30 | ¥13m |
| —segment total | revenue | 2024-10-01 → 2025-09-30 | ¥2.0bn |
| —segment total | revenue external | 2024-10-01 → 2025-09-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥1m |
| —segment total | segment profit | 2024-10-01 → 2025-09-30 | ¥511m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-10-01 → 2025-09-30 | ¥262m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-10-01 → 2025-09-30 | ¥13m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥322,000 |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥745,000 |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-09-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥393m |
| Direct To Consumer Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| Direct To Consumer Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.3bn |
| Direct To Consumer Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.3bn |
| Direct To Consumer Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥75,000 |
| Direct To Consumer Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥386m |
| Medical Supportreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥80m |
| Medical Supportreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥8m |
| Medical Supportreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥629m |
| Medical Supportreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥627m |
| Medical Supportreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥2m |
| Medical Supportreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥64m |
| —segment total | capex | 2023-10-01 → 2024-09-30 | ¥80m |
| —segment total | depreciation | 2023-10-01 → 2024-09-30 | ¥12m |
| —segment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.9bn |
| —segment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.9bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥2m |
| —segment total | segment profit | 2023-10-01 → 2024-09-30 | ¥450m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥80m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥450m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,221
| Item | Context | Value | Unit |
|---|---|---|---|
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(グロース) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)相川 佳之 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | SINGAPORE | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)井上 裕基 | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)SBCメディカルグループ株式会社 | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)神奈川県横浜市戸塚区上倉田町908 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社M&M | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)東京都港区浜松町２丁目２-15 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)株式会社MC | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区西新橋３丁目24-10 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)福留 大士 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)前田 敏彦 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)東京都渋谷区 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８-12 | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８番１号 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)佐俣 文平 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)神奈川県藤沢市 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容として何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36697-000SamataBunpeiMember | Original text (Japanese)代表取締役社長 海外事業部管掌 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36697-000SamataBunpeiMember | Original text (Japanese)佐俣 文平 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36697-000SamataBunpeiMember | 1985-07-02 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |